CAR T cells in solid tumors and metastasis: paving the way forward
- 24 September 2024
- journal article
- research article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 43 (4) , 1279-1296
Abstract
CAR T cell therapy, hailed as a breakthrough in cancer treatment due to its remarkable outcomes in hematological malignancies, encounters significant hurdles when applied to solid tumors. While notable responses to CAR T cells remain sporadic in these patients, challenges persist due to issues such as on-target off-tumor toxicity, difficulties in their trafficking and infiltration into the tumor, and the presence of a hostile and immunosuppressive microenvironment. This review aims to explore recent endeavors aimed at overcoming these obstacles in CAR T cell therapy for solid tumors. Specifically, we will delve into promising strategies for enhancing tumor specificity through antigen targeting, addressing tumor heterogeneity, overcoming physical barriers, and counteracting the immune-suppressive microenvironment.Keywords
Funding Information
- Italian Association for Cancer Research - AIRC 5 per Mille (22737)
- Italian Association for Cancer Research - My First AIRC Grant (27459)
This publication has 167 references indexed in Scilit:
- Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapyDrug Delivery and Translational Research, 2023
- CAR T cell therapy in solid tumors: A review of current clinical trialseJHaem, 2021
- Angiogenesis as a hallmark of solid tumors - clinical perspectivesCellular Oncology, 2021
- The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironmentCancer Letters, 2021
- Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells in vitroClinical & Translational Immunology, 2021
- CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functionsCancer Immunology, Immunotherapy, 2018
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1Cancer Cell, 2018
- Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AMLCancer Cell, 2017
- CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe targetCancer Immunology, Immunotherapy, 2017
- Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-TCancer Immunology, Immunotherapy, 2015